| a. for authorisation A | 1. 10 years, without prejudice to numbers 2–4, 2.25 years for biocidal products with an active substance which is a candidate for substitution, if a comparative assessment has been performed in accordance with Article 23 of Regulation (EU) No 528/20123, 3. 5 years for biocidal products with active substances authorised in accordance with Article 5 paragraph 2 of Regulation (EU) No 528/2012, 4. 4 years for biocidal products with an active substance which is a candidate for substitution, if no comparative assessment has been performed in accordance with Article 23 of Regulation (EU) No 528/2012; |
|---|---|
| b. for authorisation A | 1. 4 years, or 2. if earlier, until the following time: – until 3 years after the last active substance in the biocidal product has been listed in Annex 1 or 2, or – until the Notification Authority, having regard to the European Commission’s decision not to approve the active substance or include it in Annex I to Regulation (EU) No 528/2012, cancels the authorisation; |
| c. for authorisations A | 1. 6 months after the last active substance in the biocidal product is listed in Annex 1 or 2, 2. 3 years after the last active substance in the biocidal product is listed in Annex 1 or 2, provided that the authorisation holder meets the requirements of Article 22 paragraph 2, or 3. until the Notification Authority, having regard to the European Commission’s decision not to approve the active substance or include it in Annex I to Regulation (EU) No 528/2012, cancels the authorisation; |
| d.4 for derogations:5 | 1. 180 days for derogations under Article 30 paragraph 1 plus no more than 550 days if a requested extension is granted, 2. 3 years for derogations under Article 30a paragraph 1, 3. for as long as necessary for derogations under Article 30b; |
| e.6 for recognition: | for as long as the authorisation of the reference product is valid; |
| f. for recognition of a Union authorisation: | for as long as the Union authorisation is valid; |
| g. for authorisation for parallel trade: | 1. for as long as the authorisation of the reference product is valid, or 2. if the authorisation of the reference product is withdrawn at the request of the authorisation holder and the requirements specified in Article 11 are still met: until the date on which the authorisation for the reference product would normally have expired; |
| h. for the placing on the market of a biocidal product authorised under a simplified procedure in an EU or EFTA Member State: | for as long as the authorisation is valid in the EU or EFTA Member State; |
| i. for the placing on the market of a product within a biocidal product family: | for as long as the authorisation for the biocidal product family is valid; |
| j. for release for purposes of research and development: | for the declared test duration; |
| k.7 for simplified authorisation: | 10 years; |
| l.8 for the authorisation of the same biocidal products: | 1. – 10 years for authorisations based on an ordinary authorisation Z |
2–4. .9 5. If the authorisation has expired, Article 26a governs any further placing on the market, supply to end consumers and the professional or commercial use of the biocidal product.10
Amended by No I of the O of 31 Jan. 2018, in force since 1 March 2018 (AS 2018 817). ↩
Amended by No I of the O of 5 June 2015, in force since 1 July 2015 (AS 2015 1985). ↩
See footnote to Art. 1b para. 3. ↩
Amended by No I of the O of 31 Jan. 2018, in force since 1 March 2018 (AS 2018 817). ↩
Correction of 24 Sept. 2019 (AS 2019 3037). ↩
Amended by No I of the O of 18 Nov. 2020, in force since 15 Dec. 2020 (AS 2020 5125). ↩
Inserted by No I of the O of 5 June 2015, in force since 1 July 2015 (AS 2015 1985). ↩
Inserted by No I of the O of 31 Jan. 2018, in force since 1 March 2018 (AS 2018 817). ↩
Repealed by No I of the O of 31 Jan. 2018, with effect from 1 March 2018 (AS 2018 817). ↩
Amended by No I of the O of 31 Jan. 2018, in force since 1 March 2018 (AS 2018 817). ↩
0 commentaries